Correlation Between Cyclacel Pharmaceuticals and OncoSec Medical

Can any of the company-specific risk be diversified away by investing in both Cyclacel Pharmaceuticals and OncoSec Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclacel Pharmaceuticals and OncoSec Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cyclacel Pharmaceuticals and OncoSec Medical, you can compare the effects of market volatilities on Cyclacel Pharmaceuticals and OncoSec Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclacel Pharmaceuticals with a short position of OncoSec Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclacel Pharmaceuticals and OncoSec Medical.

Diversification Opportunities for Cyclacel Pharmaceuticals and OncoSec Medical

0.83

Correlation Coefficient

Cyclacel Pharmaceuticals  OncoSec Medical

Very poor diversification

The 3 months correlation between Cyclacel and OncoSec is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Cyclacel Pharmaceuticals and OncoSec Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoSec Medical and Cyclacel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclacel Pharmaceuticals are associated (or correlated) with OncoSec Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoSec Medical has no effect on the direction of Cyclacel Pharmaceuticals i.e., Cyclacel Pharmaceuticals and OncoSec Medical go up and down completely randomly.

Pair Corralation between Cyclacel Pharmaceuticals and OncoSec Medical

If you would invest  5.84  in OncoSec Medical on September 3, 2024 and sell it today you would earn a total of  0.00  from holding OncoSec Medical or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	1.56%
Values	Daily Returns

Cyclacel Pharmaceuticals  vs.  OncoSec Medical

Cyclacel Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cyclacel Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

OncoSec Medical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days OncoSec Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, OncoSec Medical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Cyclacel Pharmaceuticals and OncoSec Medical

The main advantage of trading using opposite Cyclacel Pharmaceuticals and OncoSec Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclacel Pharmaceuticals position performs unexpectedly, OncoSec Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoSec Medical will offset losses from the drop in OncoSec Medical's long position.

The idea behind Cyclacel Pharmaceuticals and OncoSec Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.